Table 1. Baseline demographic and clinical characteristics of HIV-infected women who received care at Kalembelembe Pediatric Hospital and Bomoi Healthcare Center in Kinshasa, DRC, 2007–2013 (N = 2175).
| Characteristic | Total (n = 2175) | Pregnant (n = 1497) | Not pregnant (n = 678) | P |
|---|---|---|---|---|
| Year of enrollment, n (%) | <0.0001^ | |||
| 2007–2009 | 982 (45.1) | 768 (51.3) | 214 (31.6) | |
| 2010–2013 | 1193 (54.9) | 729 (49.7) | 464 (68.4) | |
| Age, n (%) | <0.0001^ | |||
| 15–24 | 372 (17.1) | 273 (18.2) | 99 (14.6) | |
| 25–34 | 1301 (59.8) | 938 (62.7) | 363 (53.5) | |
| 35–45 | 502 (23.1) | 286 (19.1) | 216 (31.9) | |
| WHO clinical stage, n (%) | <0.0001^ | |||
| Stage I or II | 1848 (85.0) | 1351 (90.2) | 497 (73.3) | |
| Stage III or IV | 312 (14.3) | 134 (9.0) | 178 (26.3) | |
| Missing | 15 (0.7) | 12 (0.8) | 3 (0.4) | |
| CD4 count, median cells/mm3 (IQR) | 356 (215–534) | 349 (224–515) | 366 (196–574) | 0.31& |
| ART initiated within 3 months of enrollment, n (%) | 802 (36.9) | 506 (33.8) | 296 (43.7) | <0.0001^ |
| Median years of follow-up (IQR) | 4 (3–6) | 4 (3–5) | 5 (3–6) | <0.0001& |
| No follow-up after enrollment, n (%) | 131 (6.0) | 106 (7.1) | 25 (3.7) | <0.0001^ |
| Lost to care, n (%)* | 860 (42.1) | 572 (41.0) | 288 (43.8) | 0.60^ |
| Transferred to another facility | 32 (1.5) | 21 (1.4) | 11 (1.6) | 0.69^ |
| Died | 91 (4.2) | 56 (3.7) | 35 (5.2) | 0.13^ |
DRC = Democratic Republic of Congo.
IQR = interquartile range.
WHO = World Health Organization.
ART = antiretroviral therapy.
^ represents probability of observed result using chi-squared test of independence.
& represents probability of observed result using Wilcoxon Rank-Sum test.
* denominators do not include the 131 women (106 pregnant and 25 not pregnant) who did not return after the enrollment visit.